Concepedia

Mark Nazzaro

MN

Statistics

Publications

4

Citations

145

H-Index

4

Active since

2015

Affiliations

Mersana Therapeutics (United States)(Current)

Mark Nazzaro is an author at Mersana Therapeutics (United States) specializing in antibody-drug conjugates, antibody conjugates, and pharmacology.

Publications per year

2015–2023

4

Publications

4

Characterization of Intact Protein Conjugates and Biopharmaceuticals Using Ion-Exchange Chromatography with Online Detection by Native Electrospray Ionization Mass Spectrometry and Top-Down Tandem Mass Spectrometry

Khaja Muneeruddin, Mark Nazzaro, Igor A. Kaltashov · Analytical Chemistry · 2015 · 99 citations

Life Sciences, Biochemistry, Pharmacology +17

Abstract 6706: Systemic administration of STING agonist antibody-drug conjugates elicit potent anti-tumor immune responses with minimal induction of circulating cytokines

Raghida A. Bukhalid, Jeremy R. Duvall, Naniye Mallı Cetinbas et al. · Cancer Research · 2020 · 25 citations

Pharmacy, Immunology, Oncology +16

Abstract 2894: XMT-1592, a site-specific Dolasynthen-based NaPi2b-targeted antibody-drug conjugate for the treatment of ovarian cancer and lung adenocarcinoma

Shawn P. Fessler, Anouk Dirksen, Scott D. Collins et al. · Cancer Research · 2020 · 11 citations

Pharmacy, Oncology, Pharmacology +16

Site-Specific Dolasynthen Antibody–Drug Conjugates Exhibit Consistent Pharmacokinetic Profiles across a Wide Range of Drug-to-Antibody Ratios

Susan M. Clardy, Alex Uttard, Bingfan Du et al. · Molecular Cancer Therapeutics · 2023 · 10 citations

Pharmacy, Pharmaceutics, Pharmacology +17

1–4 of 4